1-O-十八烷基-2-O-甲基-sn-甘油-3-磷酸胆碱 | 77286-66-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油磷脂
• 中文名称: 1-O-十八烷基-2-O-甲基-sn-甘油-3-磷酸胆碱
• 中文别名: 中文名称暂缺
• 英文名称: (+)-Edelfosine
• 英文别名: 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine；[(2R)-2-methoxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
• CAS: 77286-66-9
• 化学式: C₂₇H₅₈NO₆P
• 分子量: 523.734
• InChiKey: MHFRGQHAERHWKZ-HHHXNRCGSA-N

物化性质

• 溶解度：
  乙醇：15 mg/mLat 45 °C，可溶
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  35
• 可旋转键数：
  27
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  77
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 安全说明：
  S22,S24/25
• WGK Germany：
  3

SDS

Name:	1-O-Octadecyl-2-O-Methyl-Sn-Glycero-3-Phosphocholine Material Safety Data Sheet
Synonym:	Sn-ET-18-OCH3
CAS:	77286-66-9

Section 1 - Chemical Product MSDS Name:1-O-Octadecyl-2-O-Methyl-Sn-Glycero-3-Phosphocholine Material Safety Data Sheet
Synonym:Sn-ET-18-OCH3

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
77286-66-9	1-O-Octadecyl-2-O-Methyl-SN-Glycero-3-		unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Deep freeze (below -20C).

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 77286-66-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: almost white
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C27H58NO6P
Molecular Weight: 523.3829

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of phosphorus, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 77286-66-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-O-Octadecyl-2-O-Methyl-SN-Glycero-3-Phosphocholine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 77286-66-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 77286-66-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 77286-66-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为产物：
  描述：

  (S)-1-(benzyloxy)-3-(octadecyloxy)propan-2-ol 在 palladium on activated charcoal 吡啶 、 盐酸 、 lithium aluminium tetrahydride 、 potassium tert-butylate 、 氢气 、 sodium hydride 、 三乙胺 、 三氯氧磷 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.75h， 生成 1-O-十八烷基-2-O-甲基-sn-甘油-3-磷酸胆碱
  参考文献：
  名称：

  甘油醚磷脂的合成第1部分1 - O-十八烷基-2- O-乙酰基-sn-甘油-3-磷酸胆碱1（“血小板活化因子”），对映异构体和一些类似化合物的生产† ‡

  摘要：

  甘油醚磷脂的合成，第一次通讯，对映体和一些类似化合物的1- O-十八烷基-2- O-乙酰基-sn-甘油-3-磷酸胆碱（“血小板活化因子”）的制备

  DOI：

  10.1002/hlca.19820650339

文献信息

• An effective reagent to functionalize alcohols with phosphocholine
  作者：Lianyan L. Xu、Lawrence J. Berg、D. Jamin Keith、Steven D. Townsend

  DOI：10.1039/c9ob02582k

  日期：——

  Phosphocholine is a small haptenic molecule that is both a precursor and degradation product of choline. Phosphocholine decorates a number of biologics such as lipids and oligosaccharides. In this study, an air and bench stable phosphocholine donor has been developed and evaluated with a number of alcohol acceptors. Using a one-pot, three-step sequence, (phosphitylation, oxidation, and phosphate deprotection)

  磷酸胆碱是一种小的半抗原状分子，既是胆碱的前体又是其降解产物。磷酸胆碱修饰了许多生物制品，例如脂质和寡糖。在这项研究中，开发了一种空气和实验台稳定的磷酸胆碱供体，并与许多醇受体一起进行了评估。使用一锅，三步顺序（磷酸化，氧化和磷酸脱保护），可以高产率合成磷酸胆碱衍生物。特别令人关注的是米线磷碱的合成，米线磷碱是一种被批准用于治疗利什曼病的口服药物。由于其昂贵的花费（每克1500美元），米替福辛不适用于世界上大多数患者。根据所描述的反应顺序，该药物的生产价格为每克25美元。
• D and L etherlipid stereoisomers and liposomes
  申请人：Elan Pharmaceuticals, Inc.

  公开号：US06667053B1

  公开（公告）日：2003-12-23

  A liposome having a lipid bilayer, where the lipid bilayer includes either the L or D stereoisomer of an ether lipid or a non-equal mixture of both. Most preferably the liposome also comprises (a) an underivatized phosphatidylcholine; (b) a sterol; (c) about 5-20 mole % of a phosphatidylethanolamine linked to a dicarboxylic acid at the ethanolamine group of the phosphatidylethanolamine, and (d) greater than about 10 mole % to less than about 30 mole % of either the L or D stereoisomer of an ether lipid. The liposome may be used as an anti-cancer or anti-inflammatory agent.

  一个具有脂质双分子层的脂质体，其中脂质双分子层包括醚脂类的L或D立体异构体之一或两者的非等量混合物。最好的情况是，脂质体还包括(a)未衍生的磷脂酰胆碱；(b)一种固醇；(c)约5-20摩尔％的磷脂醇胺与磷脂醇胺的乙醇胺基团上连接有二羧酸的酯化羧基，以及(d)大约10摩尔％以上但小于30摩尔％的醚脂类的L或D立体异构体。该脂质体可用作抗癌或抗炎药剂。
• Phospholipid derivatives having a polyhydroxylated aliphatic carbocycle
  申请人：Reutter, Werner, Prof. Dr.

  公开号：EP1421941A1

  公开（公告）日：2004-05-26

  The present invention relates to a phospholipid derivative having a substituted or unsubstituted polyhydroxylated aliphatic carbocycle attached to the sn-1 or sn-2 position of the glycerol backbone, a pharmaceutical composition comprising said phospholipid, a method for preparing said phospholipid and a medicament comprising said phospholipid.

  本发明涉及一种磷脂衍生物，其具有连接到甘油骨架的sn-1或sn-2位置的取代或未取代的多羟基脂肪环，以及包含该磷脂衍生物的药物组合物、制备该磷脂衍生物的方法和包含该磷脂衍生物的药物。
• Functional associative coatings for nanoparticles
  申请人：Hainfeld James F.

  公开号：US20080089836A1

  公开（公告）日：2008-04-17

  Described herein are nanoparticles that are coated with a bilayer of molecules formed from surface binding molecules and amphiphatic molecules. The bilayer coating self assembles on the nanoparticles from readily available materials/molecules. The modular design of the bilayer coated nanoparticles provides a means for readily and efficiently optimizing the properties of the bilayer coated nanoparticle compositions. Also described herein are uses of such nanoparticles in medicine, laboratory techniques, industrial and commerical applications.

  本文描述了一种纳米颗粒，其表面涂覆有由表面结合分子和两亲分子形成的双层分子层。该双层涂层可以自组装在纳米颗粒上，使用易得的材料/分子。双层涂层纳米颗粒的模块化设计提供了一种方便和高效地优化其性质的方法。此外，本文还描述了这种纳米颗粒在医学、实验室技术、工业和商业应用中的用途。
• Inositolized phospholipids
  申请人：Danker Kerstin

  公开号：US20060105996A1

  公开（公告）日：2006-05-18

  The present invention relates to a phospholipid dreivative having a substituted or unsubstituted polyhydroxylated aliphatic carbocycle attached to the sn-1 or sn-2 position of the glycerol backbone, a pharmaceutical composition comprising said phospholipid, a method for preparing said phospholipid and a medicament comprising said phospholipid.

  本发明涉及一种磷脂衍生物，其具有连接到甘油骨架的sn-1或sn-2位置的取代或未取代的多羟基脂肪环，以及包含该磷脂的制药组合物、制备该磷脂的方法和包含该磷脂的药物。